Related Experiment Video

Updated: Oct 17, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

492

CARRA: The Childhood Arthritis and Rheumatology Research Alliance

Robert C Fuhlbrigge1, Laura E Schanberg2, Yukiko Kimura3

  • 1Children's Hospital Colorado, University of Colorado, 13123 E. 16th Ave., Rheumatology B-311, Aurora, CO 80045, USA.

Rheumatic Diseases Clinics of North America
|October 12, 2021
PubMed

Insights

The Childhood Arthritis & Rheumatology Research Alliance (CARRA) has significantly advanced pediatric rheumatology research and care since 2000. This collaborative network drives evidence-based medicine and supports career development for improved outcomes in childhood rheumatic diseases.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Research Networks
  • Rheumatic Diseases in Children

Background:

  • Established in 2000, the Childhood Arthritis & Rheumatology Research Alliance (CARRA) began as a small network.
  • Focused on pediatric rheumatologists and investigators to foster collaborative research.
  • Aimed to enhance the care and outcomes for childhood-onset rheumatic diseases.

Purpose of the Study:

  • To summarize the growth and impact of CARRA over two decades.
  • To highlight CARRA's role in advancing evidence-based medicine in pediatric rheumatology.
  • To emphasize CARRA's contribution to career development within the field.

Main Methods:

  • Longitudinal analysis of CARRA's development and research initiatives.
  • Review of CARRA's contributions to evidence-based medicine.
  • Assessment of CARRA's impact on the field of pediatric rheumatology.

Main Results:

  • CARRA has evolved from a small network into a major force in pediatric rheumatology research.
  • The organization has driven significant advances in evidence-based medicine.
  • CARRA has become instrumental in fostering career development for pediatric rheumatologists.

Conclusions:

  • CARRA's collaborative research approach has transformed pediatric rheumatology.
  • The organization continues to be a vital platform for impactful research in childhood rheumatic diseases.
  • CARRA is poised to further facilitate advancements in the care of young patients with rheumatic conditions.

Keywords:
ConsensusPediatricRegistryRheumatic disease

More Related Videos

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

2.5K
A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit08:42

A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit

Published on: November 21, 2023

1.4K

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
890
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
97
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
121
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
58